Heritable vaginal bacteria influence immune tolerance and relate to early-life markers of allergic sensitization in infancy
- PMID: 35932762
- PMCID: PMC9418802
- DOI: 10.1016/j.xcrm.2022.100713
Heritable vaginal bacteria influence immune tolerance and relate to early-life markers of allergic sensitization in infancy
Abstract
Maternal asthma status, prenatal exposures, and infant gut microbiota perturbation are associated with heightened risk of atopy and asthma risk in childhood, observations hypothetically linked by intergenerational microbial transmission. Using maternal vaginal (n = 184) and paired infant stool (n = 172) samples, we identify four compositionally and functionally distinct Lactobacillus-dominated vaginal microbiota clusters (VCs) that relate to prenatal maternal health and exposures and infant serum immunoglobulin E (IgE) status at 1 year. Variance in bacteria shared between mother and infant pairs relate to VCs, maternal allergy/asthma status, and infant IgE levels. Heritable bacterial gene pathways associated with infant IgE include fatty acid synthesis and histamine and tryptophan degradation. In vitro, vertically transmitted Lactobacillus jensenii strains induce immunosuppressive phenotypes on human antigen-presenting cells. Murine supplementation with L. jensenii reduces lung eosinophils, neutrophilic expansion, and the proportion of interleukin-4 (IL-4)+ CD4+ T cells. Thus, bacterial and atopy heritability are intimately linked, suggesting a microbial component of intergenerational disease transmission.
Keywords: Lactobacillus; asthma; atopy; immune tolerance; inherited bacteria; microbiota; prenatal; transmission; vaginal; vaginal microbiota.
Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests J.E.G. is a paid consultant for AstraZeneca, Meissa Vaccines Inc., and Gossamer Bio and has stock options in Meissa Vaccines Inc. H.A.B. serves on a scientific advisory committee for Siolta Therapeutics Inc. S.V.L. is a co-founder and member of the board and consults for and holds stock options in Siolta Therapeutics Inc.; she also consults for Solarea Bio. The Regents of UCSF have filed a patent application (PCT/US2019/045,354) on behalf of S.V.L. and E.R. relating to the methods and compositions of fetal bacteria.
Figures







References
-
- Arrieta M.-C., Stiemsma L.T., Dimitriu P.A., Thorson L., Russell S., Yurist-Doutsch S., Kuzeljevic B., Gold M.J., Britton H.M., Lefebvre D.L., et al. Early infancy microbial and metabolic alterations affect risk of childhood asthma. Sci. Transl. Med. 2015;7:307ra152. - PubMed
-
- Levan S.R., Stamnes K.A., Lin D.L., Panzer A.R., Fukui E., McCauley K., Fujimura K.E., McKean M., Ownby D.R., Zoratti E.M., et al. Elevated faecal 12, 13-diHOME concentration in neonates at high risk for asthma is produced by gut bacteria and impedes immune tolerance. Nat. Microbiol. 2019;4:1851–1861. - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases